High-sensitivity C-reactive protein and cognitive impairment among African stroke survivors

Published: 5 January 2021| Version 1 | DOI: 10.17632/r5vkhkdh3z.1


This data set contains socio-demographic, clinical and laboratory variables, including cognitive performance assessment test results and high-sensitivity C-reactive protein (hsCRP), of stroke survivors and matched controls. Included are raw data and well as outputs of statistical analyses, including test of normality, log transformation and summary statistics. The study aimed to assess cognitive impairment and serum levels of pro-inflammatory hsCRP and their relationships, in stroke patients during the early phases of post-stroke recovery. Presence of cognitive impairment and correlations with an active inflammatory status in these patients was hypothesized. The data were obtained from 30 stroke survivor within 2-3 months following stroke and 30 control subjects without stroke. Cognitive function was assessed using Montreal cognitive assessment test, while hsCRP was measured using an ELISA kit (Calbiotech, U.S.A.). Clinical and socio-demographic data were obtained during an interview and clinical examination. Our data demonstrate high prevalence of cognitive impairment and very high levels of hsCRP among majority of the stroke survivors, in contrast to their non-stroke controls. These data bring evidence of cognitive impairment with concurrent high level of inflammation and their correlations in an African population of stroke survivors.



Bayero University


Inflammation, Dementia, Cognitive Impairment, Stroke